16.05.2018 23:00:00

Anaconda Mining announces election of board of directors

TORONTO, May 16, 2018 /CNW/ - Anaconda Mining Inc. ("Anaconda" or the "Company") – (TSX:ANX, OTCQX: ANXGF) is pleased to announce that the nominees listed in the management information circular for the 2018 Annual General Meeting were elected as directors of the Company. Detailed results of the vote for the election of directors held at the Annual General Meeting on May 16, 2018 in Toronto are set out below.

Nominee

Votes For

% For

Votes Withheld

% Withheld

Dustin Angelo

19,950,213

84.07%

3,780,989

15.93%

Michael Byron

20,824,856

87.75%

2,906,346

12.25%

Jonathan Fitzgerald

22,740,891

95.83%

990,311

4.17%

Jacques Levesque

21,248,264

89.54%

2,482,938

10.46%

Lewis Lawrick      

20,849,852

87.86%

2,881,350

12.14%

Maruf Raza         

20,807,352

87.68%

2,923,850

12.32%

 

In addition, PricewaterhouseCoopers LLP were appointed as the auditors of the Company for the ensuing year and the directors were authorized to fix their remuneration.

ABOUT ANACONDA MINING INC.

Anaconda is a TSX-listed gold mining, development, and exploration company, focused in the prospective Atlantic Canadian jurisdictions of Newfoundland and Nova Scotia. The Company operates the Point Rousse Project located in the Baie Verte Mining District in Newfoundland, comprised of the Stog'er Tight Mine, the Pine Cove open pit mine, the Argyle Mineral Resource, the fully-permitted Pine Cove Mill and tailings facility, a deep-water port, and approximately 5,800 hectares of prospective gold-bearing property. Anaconda is also developing the Goldboro Project in Nova Scotia, a high-grade Mineral Resource, with the potential to leverage existing infrastructure at the Company's Point Rousse Project.

The Company also has a pipeline of organic growth opportunities, including the Great Northern Project on the Northern Peninsula of Newfoundland and the Tilt Cove Property on the Baie Verte Peninsula, also in Newfoundland.

SOURCE Anaconda Mining Inc.

Nachrichten zu Mast Therapeutics Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Mast Therapeutics Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!